Komirishetty Prashanth, Areti Aparna, Sistla Ramakrishna, Kumar Ashutosh
Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research (NIPER)-Hyderabad, Balanagar, Hyderabad, Telangana State, 500037, India.
Medicinal Chemistry and Pharmacology Division, Indian Institute of Chemical Technology (IICT), Hyderabad, India.
Neurochem Res. 2016 Aug;41(8):2029-42. doi: 10.1007/s11064-016-1914-0. Epub 2016 Apr 15.
Neuropathic pain is initiated or caused due to the primary lesion or dysfunction in the nervous system and is proposed to be linked to a cascade of events including excitotoxicity, oxidative stress, neuroinflammation and apoptosis. Oxidative/nitrosative stress aggravates the neuroinflammation and neurodegeneration through poly (ADP) ribose polymerase (PARP) overactivation. Hence, the present study investigated the antioxidant and anti-inflammatory effects of the phytoconstituent; morin in chronic constriction injury (CCI) induced neuropathy. Neuropathic pain was induced by chronic constriction of the left sciatic nerve in rats, and the effect of morin (15 and 30 mg/kg, p.o.) was evaluated by measuring behavioural and biochemical changes. Mechanical, chemical and thermal stimuli confirmed the CCI-induced neuropathic pain and treatment with morin significantly improved these behavioural deficits and improved the sciatic functional index by the 14th day after CCI induction. After 14 days of CCI induction, oxidative/nitrosative stress and inflammatory markers were elevated in rat lumbar spinal cord. Oxidative stress induced PARP overactivation resulted in depleted levels of ATP and elevated levels of poly (ADP) ribose (PAR). Treatment with morin reduced the levels of nitrites, restored glutathione levels and abrogated the oxidant induced DNA damage. It also mitigated the increased levels of TNF-α and IL-6. Protein expression studies confirmed the PARP inhibition and anti-inflammatory activity of morin. Findings of this study suggest that morin, by virtue of its antioxidant properties, limited PARP overactivation and neuroinflammation and protected against CCI induced functional, behavioural and biochemical deficits.
神经性疼痛是由神经系统的原发性损伤或功能障碍引发或导致的,据推测与一系列事件有关,包括兴奋性毒性、氧化应激、神经炎症和细胞凋亡。氧化/亚硝化应激通过多聚(ADP)核糖聚合酶(PARP)过度激活加重神经炎症和神经退行性变。因此,本研究调查了植物成分桑色素在慢性压迫性损伤(CCI)诱导的神经病变中的抗氧化和抗炎作用。通过慢性压迫大鼠左侧坐骨神经诱导神经性疼痛,并通过测量行为和生化变化来评估桑色素(15和30mg/kg,口服)的作用。机械、化学和热刺激证实了CCI诱导的神经性疼痛,桑色素治疗显著改善了这些行为缺陷,并在CCI诱导后第14天提高了坐骨神经功能指数。在CCI诱导14天后,大鼠腰脊髓中的氧化/亚硝化应激和炎症标志物升高。氧化应激诱导的PARP过度激活导致ATP水平降低和多聚(ADP)核糖(PAR)水平升高。桑色素治疗降低了亚硝酸盐水平,恢复了谷胱甘肽水平,并消除了氧化剂诱导的DNA损伤。它还减轻了TNF-α和IL-6水平的升高。蛋白质表达研究证实了桑色素的PARP抑制和抗炎活性。本研究结果表明,桑色素凭借其抗氧化特性,限制了PARP过度激活和神经炎症,并预防了CCI诱导的功能、行为和生化缺陷。